Oxurion Announces Capital Increase via Bond Conversion

Oxurion NV announced the conversion of 10 convertible bonds by Atlas Special Opportunities, LLC, resulting in a capital increase of EUR 250,000. This move is part of a EUR 20 million capital commitment by Atlas to support the development of innovative treatments to preserve sight in older adults, targeting a potential market of USD 3 to 6 billion.

Following this conversion, Oxurion issued 11,161,618 new ordinary shares, bringing the total to 36,983,581 shares. These shares will serve as a reference for calculating the ownership percentages. With a total capital of EUR 86,406,161.32, all issued shares confer voting rights.

Oxurion is continuing its financing strategy thanks to Atlas' commitment, thus increasing its development capabilities and meeting legal requirements for disclosing significant holdings on the stock market.